CX

Federal Funding Cut Hits Longtime Marijuana Monitoring Program The U.S. government has abruptly canceled a long-running research program tracking marijuana potency in seized drugs—marking another swing of the budget-cutting axe …

Balancing Cannabis Use and Workplace Safety: New Challenges in a Legal EraAs marijuana legalization spreads, employers face a growing dilemma: how to uphold safety and productivity without infringing on workers’ …

Scientists in South Korea have uncovered rare chemical compounds in cannabis flowers that significantly inhibit the growth of neuroblastoma cells, a common pediatric cancer. Researchers Reveal Anticancer Potential in Cannabis …

Edibles, Vapes, and Dabs: The New Face of Cannabis Consumption in the U.S. Marijuana isn’t just being smoked anymore. More Americans are turning to edibles, vape pens, and dabs — …

Breakthrough research suggests cannabis terpenes could transform treatment for conditions like fibromyalgia and post-surgical pain—without the risks of THC or opioids Cannabis has become a familiar tool in modern medicine …

As California’s cannabis industry grows into a multibillion-dollar powerhouse, its expansion is sparking unexpected tensions—with the state’s iconic wine industry. Vineyards and cannabis farms now share more than just the …

In a major move set to redefine hemp cultivation in the U.S., California cannabis giant Glass House Brands has joined forces with the University of California, Berkeley, to dive deep …

Once hailed as a beacon of social justice and economic promise, New York’s legal cannabis rollout is under scrutiny as investigations loom over the state’s top marijuana agency. When New …

A new study suggests that cancer patients who use cannabis may require lower doses of sedative medication during medical procedures — a finding that could reshape how comfort and safety …